Back
Catalyst Pharmaceuticals Vs. Savara Industry Stock Comparison
Sell
45
CPRX
Catalyst Pharmaceuticals
Last Price:
15.11
Seasonality Move:
2.11%
Buy
54
SVRA
Savara
Last Price:
4.71
Seasonality Move:
3.9%
Sell
45
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $15.11. The Score for CPRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Savara (SVRA)
is a Buy
Is Savara a Buy, Sell or Hold?
- The current Savara [SVRA] share price is $4.71. The Score for SVRA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- SVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $15.11
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight selling pressure.
SVRA Stock Price Chart
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 44.35 | Sell |
| Chaikin Money Flow: | -112021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.25 - 16.19) | Sell |
| Bollinger Bands (100): | (14.01 - 16.19) | Buy |
SVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.07 | Sell |
| Chaikin Money Flow: | -491683 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.7 - 5.02) | Sell |
| Bollinger Bands (100): | (4.33 - 5.11) | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.44 | Sell |
| 20-day SMA: | 15.57 | Sell |
| 50-day SMA: | 15.39 | Sell |
| 200-day SMA: | 14.16 | Buy |
| 8-day EMA: | 15.39 | Sell |
| 20-day EMA: | 15.54 | Sell |
| 50-day EMA: | 15.41 | Sell |
| 200-day EMA: | 14.57 | Buy |
SVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.99 | Sell |
| 20-day SMA: | 4.87 | Sell |
| 50-day SMA: | 4.96 | Sell |
| 200-day SMA: | 4.15 | Buy |
| 8-day EMA: | 4.87 | Sell |
| 20-day EMA: | 4.89 | Sell |
| 50-day EMA: | 4.86 | Sell |
| 200-day EMA: | 4.15 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.
Savara Earnings Growth & SVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.04 per share, and an increase next year of $0.00 per share.
Catalyst Pharmaceuticals Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Savara Technical Analysis
| Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||